A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosus
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosus
Authors
Keywords
-
Journal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-26
DOI
10.1007/s10928-020-09688-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
- (2019) Richard Furie et al. JOURNAL OF CLINICAL INVESTIGATION
- A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humans
- (2018) Konstantinos Biliouris et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
- (2016) Munther Khamashta et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms
- (2015) A. Pellerin et al. EMBO Molecular Medicine
- Optimizing outcome in SLE: treating-to-target and definition of treatment goals
- (2014) Andrea Doria et al. AUTOIMMUNITY REVIEWS
- Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel
- (2014) M Petri et al. LUPUS
- Pharmacokinetic and Pharmacodynamic Relationship of AMG 811, An Anti-IFN-γ IgG1 Monoclonal Antibody, in Patients with Systemic Lupus Erythematosus
- (2014) Ping Chen et al. PHARMACEUTICAL RESEARCH
- Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo-controlled, double-blind, dose-escalation study
- (2012) Jacqueline M. McBride et al. ARTHRITIS AND RHEUMATISM
- Complement, interferon and lupus
- (2012) Keith B Elkon et al. CURRENT OPINION IN IMMUNOLOGY
- Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea
- (2012) Mehran Ghoreishi et al. EXPERIMENTAL DERMATOLOGY
- Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer
- (2012) Lubna Abuqayyas et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification
- (2012) Lambertus A. Peletier et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
- (2011) Martin Bergstrand et al. AAPS Journal
- Current and novel therapeutics in the treatment of systemic lupus erythematosus
- (2011) Cagri Yildirim-Toruner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human
- (2011) Dhaval K. Shah et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies
- (2010) Diane R. Mould et al. BIODRUGS
- Pharmacokinetic and Pharmacodynamic Modeling of an Anti-Interleukin-6 Chimeric Monoclonal Antibody (Siltuximab) in Patients with Metastatic Renal Cell Carcinoma
- (2010) T. Puchalski et al. CLINICAL CANCER RESEARCH
- Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner's lymphocytic infiltrate of the skin and cutaneous lupus erythematosus
- (2010) Dario Tomasini et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Recommendations for the validation of flow cytometric testing during drug development: II assays
- (2010) Denise M. O'Hara et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Interferon-alpha: A Therapeutic Target in Systemic Lupus Erythematosus
- (2010) Mary K. Crow RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Selection between Michaelis–Menten and target-mediated drug disposition pharmacokinetic models
- (2009) Xiaoyu Yan et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now